Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Turecek

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Pathophysiology of Haemostasis and Thrombosis|July 11, 2003
Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assayP L Turecek, K Váradi, B Keil, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 5, 1998
Effects of human recombinant, plasma-derived and porcine von Willebrand factor in pigs with severe von Willebrand diseaseJ Roussi, P L Turecek, P André, et al.
Thrombosis and Haemostasis|October 6, 2000
von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assayJ A Dean, V S Blanchette, M D Carcao, et al.
Hamostaseologie|October 31, 2013
Development of novel treatment options for patients with haemophiliaH J Ehrlich, W Y Wong, B M Ewenstein, et al.
Cytotechnology|November 13, 2008
Strategies for recombinant Furin employment in a biotechnological process: complete target protein precursor cleavageA Preininger, U Schlokat, G Mohr, et al.
Blood|November 14, 1997
In vivo characterization of recombinant von Willebrand factor in dogs with von Willebrand diseaseP L Turecek, H Gritsch, L Pichler, et al.
Journal of Thrombosis and Haemostasis : JTH|August 26, 2016
Low ADAMTS-13 activity and the risk of coronary heart disease - a prospective cohort study: the Rotterdam StudyM A H Sonneveld, M Kavousi, M A Ikram, et al.
Blood|September 9, 1999
Evidence for extracellular processing of pro-von Willebrand factor after infusion in animals with and without severe von Willebrand diseaseP L Turecek, L Pichler, W Auer, et al.
Journal of Thrombosis and Haemostasis : JTH|August 31, 2004
Measurement of von Willebrand factor cleaving protease (ADAMTS-13): results of an international collaborative study involving 11 methods testing the same set of coded plasmasA Tripodi, V Chantarangkul, M Böhm, et al.
Hamostaseologie|September 19, 2009
Development of a plasma- and albumin-free recombinant von Willebrand factorP L Turecek, A Mitterer, H P Matthiessen, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Pathophysiology of Haemostasis and Thrombosis|July 11, 2003
Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assayP L Turecek, K Váradi, B Keil, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 5, 1998
Effects of human recombinant, plasma-derived and porcine von Willebrand factor in pigs with severe von Willebrand diseaseJ Roussi, P L Turecek, P André, et al.
Thrombosis and Haemostasis|October 6, 2000
von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assayJ A Dean, V S Blanchette, M D Carcao, et al.
Hamostaseologie|October 31, 2013
Development of novel treatment options for patients with haemophiliaH J Ehrlich, W Y Wong, B M Ewenstein, et al.
Cytotechnology|November 13, 2008
Strategies for recombinant Furin employment in a biotechnological process: complete target protein precursor cleavageA Preininger, U Schlokat, G Mohr, et al.
Blood|November 14, 1997
In vivo characterization of recombinant von Willebrand factor in dogs with von Willebrand diseaseP L Turecek, H Gritsch, L Pichler, et al.
Journal of Thrombosis and Haemostasis : JTH|August 26, 2016
Low ADAMTS-13 activity and the risk of coronary heart disease - a prospective cohort study: the Rotterdam StudyM A H Sonneveld, M Kavousi, M A Ikram, et al.
Blood|September 9, 1999
Evidence for extracellular processing of pro-von Willebrand factor after infusion in animals with and without severe von Willebrand diseaseP L Turecek, L Pichler, W Auer, et al.
Journal of Thrombosis and Haemostasis : JTH|August 31, 2004
Measurement of von Willebrand factor cleaving protease (ADAMTS-13): results of an international collaborative study involving 11 methods testing the same set of coded plasmasA Tripodi, V Chantarangkul, M Böhm, et al.
Hamostaseologie|September 19, 2009
Development of a plasma- and albumin-free recombinant von Willebrand factorP L Turecek, A Mitterer, H P Matthiessen, et al.
Pageof 6